Skip to main content

Table 1 Clinical and biochemical characteristics of the study subjects

From: Clinical utility of serum cystatin C for prediction of multi-vessel disease by coronary angiography in type 2 diabetes mellitus patients with normal renal function

 Non-diabetes (n = 179)Diabetes (n = 135)p
Age (years)54.74 ± 8.75956.41 ± 8.200.81
Males% (n)72 (129)65 (88)0.15
smoking%(n)48 (86)48 (65)0.90
Hypertension%(n)63 (113)72 (97)0.25
drinking %(n)48 (81)50 (68)0.66
BMI (kg/m2)26.32 ± 4.4226.99 ± 3.060.15
Systolic BP (mmHg)132.39 ± 17.93138.01 ± 22.690.08
Diastolic BP (mmHg)78.55 ± 12.7080.36 ± 13.390.20
FPG (mmol/L)5.27 ± 1.278.39 ± 2.57<0.001
TC (mmol/L)4.81 ± 1.074.71 ± 0.880.42
TG (mmol/L)1.91 ± 1.132.26 ± 1.410.09
LDL-c (mmol/L)2.98 ± 0.882.82 ± 0.710.09
HDL-c (mmol/L)1.14 ± 0.241.12 ± 0.880.851
SCr (μmol/L)64.13 ± 9.9762.27 ± 10.180.09
eGFR (ml/min/1.73m2)103.11 ± 7.22102.83 ± 7.500.72
UA (μmol/L)314.82 ± 74.65382.56 ± 72.670.003
Fibrinogen(g/L)3.48 ± 1.123.58 ± 0.810.41
Cystatin C (mg/L)0.75 ± 0.100.89 ± 0.11<0.001
Gensini score16.5 ± 20.0441.25 ± 33.38<0.05
  1. BMI body mass index; BP blood pressure; FPG fasting plasma glucose; TC total cholesterol; TG triglyceride; LDL-c low-density lipoprotein cholesterol; HDL-c high-density lipoprotein cholesterol; SCr serum creatinine; UA uric acid. Data are means ± SD or median (interquartile range)